BioMarin Pharmaceuticals
BMRN
BMRN
472 hedge funds and large institutions have $15.1B invested in BioMarin Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 149 increasing their positions, 187 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
472
Holders Change
+13
Holders Change %
+2.83%
% of All Funds
10.53%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.22%
New
66
Increased
149
Reduced
187
Closed
51
Calls
$138M
Puts
$119M
Net Calls
+$18.7M
Net Calls Change
+$8.83M
Top Buyers
Top Sellers
1 |
Capital Research Global Investors
Los Angeles,
California
|
-$106M |
2 |
Capital World Investors
Los Angeles,
California
|
-$106M |
3 |
Citadel Advisors
Miami,
Florida
|
-$93.8M |
4 |
BlackRock
New York
|
-$46.4M |
5 |
MNG
Manning & Napier Group
Fairport,
New York
|
-$34.5M |